Streetbeat News

Stock Prices

A significant number of investors have taken a bearish stance on Mastercard (NYSE:MA), with 68% of the detected trades being bearish and 31% bullish. The total amount for puts is $639,360 and for calls is $104,970. Whales have been targeting a price range from $330.0 to $440.0 for Mastercard over the last 3 months. The current price of MA is down -0.81% at $391.0. Truist Securities and Jefferies have maintained their Buy rating on Mastercard with a price target of $475.

Portfolio Pulse from Benzinga Insights

October 06, 2023 | 6:17 pm

CAG

ConAgra Brands Inc reported Q1 sales of $2.90 billion, flat Y/Y, versus the consensus of $2.95 billion. Adjusted EPS increased 15.8% to $0.66, beating the consensus of $0.60. Following the earnings announcement, analysts from Stifel, RBC Capital, and Jefferies lowered their price targets on ConAgra.

Portfolio Pulse from Lisa Levin

October 06, 2023 | 6:16 pm

AAPL

AMZN

GOOG

GOOGL

JPM

META

MSFT

NVDA

TSLA

JPMorgan's chief market strategist, Marko Kolanovic, has forecasted a 20% downturn in the S&P 500 due to rising interest rates. He advises investors to consider cash as a safety measure and highlights the vulnerability of seven major tech stocks: Apple, Amazon, Meta Platforms, Alphabet, Nvidia, Tesla, and Microsoft. JPMorgan is ramping up securitization to strengthen its financial standing.

Portfolio Pulse from Nabaparna Bhattacharya

October 06, 2023 | 6:12 pm

CARR

JP Morgan analyst C. Stephen Tusa has downgraded Carrier Global Corporation (CARR) to Underweight from Neutral, raising the price target to $53 from $46. Despite the company's stock outperforming its group, the analyst sees less room for growth due to weaker fundamental metrics. Tusa also notes that Trane Technologies Plc (TT) is a more attractive option based on FCF-based valuation.

Portfolio Pulse from Nabaparna Bhattacharya

October 06, 2023 | 6:11 pm

IMGN

STRO

Oppenheimer analysts have initiated coverage on Sutro Biopharma Inc (STRO) with an Outperform rating and a price target of $10, indicating a potential upside of around 200%. The analysts view Sutro as a unique clinical-stage company pioneering the development of next-generation antibody-drug conjugates (ADCs). The company's lead asset, luveltamab tazivibulin (luvelta), is a promising ADC for platinum-resistant ovarian cancer (PROC), potentially gaining a competitive edge over ImmunoGen Inc's (IMGN) Elahere.

Portfolio Pulse from Vandana Singh

October 06, 2023 | 6:05 pm

DIS

Walt Disney Co (NYSE:DIS) shares are trading higher after Bernstein initiated coverage on the company with an Outperform rating and a $103 price target. The rise in Disney's stock is also attributed to a decrease in Treasury yields, which makes it cheaper for companies to borrow money. This can reduce Disney's interest expenses when raising capital for new projects, acquisitions, or debt refinancing. Lower interest rates can also boost consumer spending on Disney's products and services.

Portfolio Pulse from Henry Khederian

October 06, 2023 | 6:04 pm

AMD

Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) are trading higher amid a rebound in tech stocks and a pullback in Treasury yields. Lower competition from fixed-income investments can drive up demand for stocks. High growth and technology stocks like AMD are often sensitive to changes in interest rates. A pullback in yields can support higher valuations for growth stocks.

Portfolio Pulse from Henry Khederian

October 06, 2023 | 6:03 pm

WEC

WEC Energy Group (NYSE:WEC) has outperformed the market over the past 20 years, producing an average annual return of 8.59%. If an investor had bought $1000 of WEC stock 20 years ago, it would be worth $5,190.98 today.

Portfolio Pulse from Benzinga Insights

October 06, 2023 | 6:01 pm

IPG

Over the past 3 months, 6 analysts have published their opinion on Interpublic Gr of Cos (NYSE:IPG) stock. The company has an average price target of $39.5, a decrease of 6.69% from the previous average price target of $42.33. The ratings include 2 bullish, 1 somewhat bullish, and 3 indifferent.

Portfolio Pulse from Benzinga Insights

October 06, 2023 | 6:00 pm

FRO

In the last quarter, Frontline (NYSE:FRO) received indifferent ratings from 4 analysts. The company's average 12-month price target is $18.05, a decrease of 5.99% from the previous average price target of $19.20.

Portfolio Pulse from Benzinga Insights

October 06, 2023 | 6:00 pm